Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie

References

• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144; PMID: 6801762; http://dx.doi.org/10.1126/science.6801762
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383; PMID: 9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr Opin Struct Biol 2009; 19:1 - 2; PMID: 19217770; http://dx.doi.org/10.1016/j.sbi.2008.12.007
   PubMed Web of Science ®Google Scholar
• Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 1044; PMID: 4964084; http://dx.doi.org/10.1038/2151043a0
   PubMed Web of Science ®Google Scholar
• Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90:10962 - 10966; PMID: 7902575; http://dx.doi.org/10.1073/pnas.90.23.10962
   PubMed Web of Science ®Google Scholar
• Gilch S, Kehler C, Schätzl HM. The prion protein requires cholesterol for cell surface localization. Mol Cell Neurosci 2006; 31:346 - 353; PMID: 16278084; http://dx.doi.org/10.1016/j.mcn.2005.10.008
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. The prion protein and lipid rafts. [review]. Mol Membr Biol 2006; 23:89 - 99; PMID: 16611584; http://dx.doi.org/10.1080/09687860500449994
   PubMed Web of Science ®Google Scholar
• Heikenwalder M, Julius C, Aguzzi A. Prions and peripheral nerves: a deadly rendezvous. J Neurosci Res 2007; 85:2714 - 2725; PMID: 17393538; http://dx.doi.org/10.1002/jnr.21246
   PubMed Web of Science ®Google Scholar
• Checler F, Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 2002; 25:616 - 620; PMID: 12446128; http://dx.doi.org/10.1016/S0166-2236(02)02263-4
   PubMed Web of Science ®Google Scholar
• Baier M, Apelt J, Riemer C, Gültner S, Schwarz A, Bamme T, et al. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1–42) and rapid scrapie disease development. Int J Dev Neurosci 2008; 26:821 - 824; PMID: 18662767; http://dx.doi.org/10.1016/j.ijdevneu.2008.07.001
   PubMed Web of Science ®Google Scholar
• Zimmermann K, Turecek PL, Schwarz HP. Genotyping of the prion protein gene at codon 129. Acta Neuropathol 1999; 97:355 - 358; PMID: 10208274; http://dx.doi.org/10.1007/s004010050998
   PubMed Web of Science ®Google Scholar
• Ironside JW, Head MW. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004; 284:133 - 159; PMID: 15148991
   PubMed Web of Science ®Google Scholar
• Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Müller U, et al. Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 2004; 63:364 - 366; PMID: 15277640
   PubMed Web of Science ®Google Scholar
• Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, et al. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging 2006; 27:770
   PubMed Web of Science ®Google Scholar
• Kageyama R, Ohtsuka T. The Notch-Hes pathway in mammalian neural development. Cell Res 1999; 9:179 - 188; PMID: 10520600; http://dx.doi.org/10.1038/sj.cr.7290016
   PubMed Web of Science ®Google Scholar
• Ishikura N, Clever JL, Bouzamondo-Bernstein E, Samayoa E, Prusiner SB, Huang EJ, et al. Notch-1 activation and dendritic atrophy in prion disease. Proc Natl Acad Sci USA 2005; 102:886 - 891; PMID: 15640354; http://dx.doi.org/10.1073/pnas.0408612101
   PubMed Web of Science ®Google Scholar
• Spilman P, Lessard P, Sattavat M, Bush C, Tousseyn T, Huang EJ, et al. A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc Natl Acad Sci USA 2008; 105:10595 - 10600; PMID: 18647832; http://dx.doi.org/10.1073/pnas.0803671105
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 1132; PMID: 19242475; http://dx.doi.org/10.1038/nature07761
   PubMed Web of Science ®Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367 - 6374; PMID: 20445063; http://dx.doi.org/10.1523/JNEUROSCI.0395-10.2010
   PubMed Web of Science ®Google Scholar
• Imbimbo BP, Del Giudice E, Colavito D, D'Arrigo A, Dalle Carbonare M, Villetti G, et al. 1-(3′,4′-Dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity. J Pharmacol Exp Ther 2007; 323:822 - 830; PMID: 17895400; http://dx.doi.org/10.1124/jpet.107.129007
   PubMed Web of Science ®Google Scholar
• Imbimbo BP, Hutter-Paier B, Villetti G, Facchinetti F, Cenacchi V, Volta R, et al. CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. Br J Pharmacol 2009; 156:982 - 993; PMID: 19239474; http://dx.doi.org/10.1111/j.1476-5381.2008.00097.x
   PubMed Web of Science ®Google Scholar
• Imbimbo BP, Giardino L, Sivilia S, Giuliani A, Gusciglio M, Pietrini V, et al. CHF5074, a novel γ-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 2010; 20:159 - 173; PMID: 20164581
   PubMed Web of Science ®Google Scholar
• Peretto I, Radaelli S, Parini C, Zandi M, Raveglia LF, Dondio G, et al. Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of β-amyloid(1–42) secretion. J Med Chem 2005; 48:5705 - 5720; PMID: 16134939; http://dx.doi.org/10.1021/jm0502541
   PubMed Web of Science ®Google Scholar
• Thackray AM, Klein MA, Aguzzi A, Bujdoso R. Chronic subclinical prion disease induced by low-dose inoculum. J Virol 2002; 76:2510 - 2517; PMID: 11836429; http://dx.doi.org/10.1128/jvi.76.5.2510-7.2002
   PubMed Web of Science ®Google Scholar
• Meeker HC, Ye X, Carp RI. The mouse model for scrapie: inoculation, clinical scoring and histopathological techniques. Methods Mol Biol 2005; 299:309 - 323; PMID: 15980614
   PubMedGoogle Scholar
• Fraser H, Dickinson AG. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 1968; 78:301 - 311; PMID: 4970192; http://dx.doi.org/10.1016/0021-9975(68)90006-6
   PubMed Web of Science ®Google Scholar
• Khalili-Shirazi A, Summers L, Linehan J, Mallinson G, Anstee D, Hawke S, et al. PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol 2005; 86:2635 - 2644; PMID: 16099923; http://dx.doi.org/10.1099/vir.0.80375-0
   PubMed Web of Science ®Google Scholar
• Doré G, Leclerc C, Lazarini F. Treatment by CpG or Flt3-ligand does not affect mouse susceptibility to BSE prions. J Neuroimmunol 2008; 197:74 - 80; PMID: 18495254; http://dx.doi.org/10.1016/j.jneuroim.2008.03.016
   PubMed Web of Science ®Google Scholar
• Mallucci G, Dickinson A, Linehan J, Klöhn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302:871 - 874; PMID: 14593181; http://dx.doi.org/10.1126/science.1090187
   PubMed Web of Science ®Google Scholar
• Meeker HC, Ye X, Carp RI. The mouse model for scrapie: inoculation, clinical scoring and histopathological techniques. Methods Mol Biol 2005; 299:309 - 323; PMID: 15980614
   PubMedGoogle Scholar
• Lee YJ, Jin JK, Jeong BH, Carp RI, Kim YS. Increased expression of glial cell line-derived neurotrophic factor (GDNF) in the brains of scrapie-infected mice. Neurosci Lett 2006; 410:178 - 182; PMID: 17101222; http://dx.doi.org/10.1016/j.neulet.2006.09.090
   PubMed Web of Science ®Google Scholar
• Lichtenstein MP, Carriba P, Baltrons MA, Wojciak-Stothard B, Peterson JR, García A, et al. Secretase-independent and RhoGTPase/PAK/ERK-dependent regulation of cytoskeleton dynamics in astrocytes by NSAIDs and derivatives. J Alzheimers Dis 2010; 22:1135 - 1155; PMID: 20930267
   PubMed Web of Science ®Google Scholar
• Brown DR, Herms J, Kretzschmar HA. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 1994; 5:2057 - 2060; PMID: 7865744; http://dx.doi.org/10.1097/00001756-199410270-00017
   PubMed Web of Science ®Google Scholar
• Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 1347; PMID: 8100741; http://dx.doi.org/10.1016/0092-8674(93)90360-3
   PubMed Web of Science ®Google Scholar
• Balducci C, Mehdawy B, Mare L, Giuliani A, Lorenzini L, Sivilia S, et al. The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice. J Alzheimers Dis 2011; 24:799 - 816; PMID: 21321397
   PubMed Web of Science ®Google Scholar
• Evin G, Sernee MF, Masters CL. Inhibition of γ-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies. CNS Drugs 2006; 20:351 - 372; PMID: 16696577; http://dx.doi.org/10.2165/00023210-200620050-00002
   PubMed Web of Science ®Google Scholar
• Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001; 276:37743 - 37746; PMID: 11477090
   PubMed Web of Science ®Google Scholar
• Sanghera N, Pinheiro TJ. Binding of prion protein to lipid membranes and implications for prion conversion. J Mol Biol 2002; 315:1241 - 1256; PMID: 11827491; http://dx.doi.org/10.1006/jmbi.2001.5322
   PubMed Web of Science ®Google Scholar
• Walmsley AR, Zeng F, Hooper NM. The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J Biol Chem 2003; 278:37241 - 37248; PMID: 12865430; http://dx.doi.org/10.1074/jbc.M302036200
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-β proteins. Semin Cell Dev Biol 2007; 18:638 - 648; PMID: 17822928; http://dx.doi.org/10.1016/j.semcdb.2007.07.008
   PubMed Web of Science ®Google Scholar
• Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996; 15:1255 - 1264; PMID: 8635458
   PubMed Web of Science ®Google Scholar